I started serious Investing Journey in Jan 2000 to create wealth through long-term investing and short-term trading; but as from April 2013 my Journey in Investing has changed to create Retirement Income for Life till 85 years old in 2041 for two persons over market cycles of Bull and Bear.

Since 2017 after retiring from full-time job as employee; I am moving towards Investing Nirvana - Freehold Investment Income for Life investing strategy where 100% of investment income from portfolio investment is cashed out to support household expenses i.e. not a single cent of re-investing!

It is 57% (2017 to Aug 2022) to the Land of Investing Nirvana - Freehold Income for Life!


Click to email CW8888 or Email ID : jacobng1@gmail.com



Welcome to Ministry of Wealth!

This blog is authored by an old multi-bagger blue chips stock picker uncle from HDB heartland!

"The market is not your mother. It consists of tough men and women who look for ways to take money away from you instead of pouring milk into your mouth." - Dr. Alexander Elder

"For the things we have to learn before we can do them, we learn by doing them." - Aristotle

It is here where I share with you how I did it! FREE Education in stock market wisdom.

Think Investing as Tug of War - Read more? Click and scroll down



Important Notice and Attention: If you are looking for such ideas; here is the wrong blog to visit.

Value Investing
Dividend/Income Investing
Technical Analysis and Charting
Stock Tips

Wednesday 2 November 2011

Q2 FY12 Performance Highlights:

  • Consecutive 12 quarters of high revenue growth with total revenue reaching US$62.2M (71% year-on-year growth)


  • Sales of Interventional Cardiology Products (“IVP”) recorded robust year-on-year increase of 31% at US$38.4M, driven primarily by the strong sales of the Company’s flagship BioMatrix™ family of drug-eluting stents (“DES”)

  • Net profit increased 171% year-on-year to US$22.9M

  • Completed acquisition of the remaining 50% equity in JW Medical Systems Limited (“JWMS”) on 3 October 2011

  • Terumo Corporation, the Company’s licensing partner, continues to record strong revenue growth after it commenced sales of the Nobori DES in Japan in May. This led to a five-fold increase in licensing revenue, year-on-year, for the Company

No comments:

Post a Comment

Related Posts with Thumbnails